Ticker League

Operating Cash Flow for Thermo Fisher Scientific (TMO)

As of · Reported

Metric

Latest period

$1.19B

YoY change

-9.8%

5Y CAGR

-1.2%

Peak year (2021)

$9.54B

Operating Cash Flow history chart for Thermo Fisher Scientific (TMO) from 1989 to 2025

Latest: $7.82B

Operating Cash Flow growth chart for Thermo Fisher Scientific (TMO) from 1989 to 2025

Latest: -9.8%

Operating Cash Flow history table for Thermo Fisher Scientific (TMO) from 1989 to 2025

  • 2025$7.82B-9.8%
  • 2024$8.67B+3.1%
  • 2023$8.41B-8.2%
  • 2022$9.15B-4.1%
  • 2021$9.54B+15.1%
  • 2020$8.29B+66.7%
  • 2019$4.97B+9.5%
  • 2018$4.54B+13.4%
  • 2017$4.00B+26.9%
  • 2016$3.16B+12.0%
  • 2015$2.82B+7.5%
  • 2014$2.62B+30.3%
  • 2013$2.01B-1.4%
  • 2012$2.04B+20.6%
  • 2011$1.69B+12.9%
  • 2010$1.50B-9.7%
  • 2009$1.66B+16.8%
  • 2008$1.42B-4.3%
  • 2007$1.48B+265.7%
  • 2006$405.65M+49.7%
  • 2005$270.91M+2.4%
  • 2004$264.51M+22.1%
  • 2003$216.72M+110.6%
  • 2002$102.89M-45.4%
  • 2001$188.40M-5.8%
  • 2000$199.92M-40.7%
  • 1999$337.12M+2.6%
  • 1998$328.50M+22.1%
  • 1997$269.00M+19.8%
  • 1996$224.50M+15.4%
  • 1995$194.60M-4.7%
  • 1994$204.20M+61.2%
  • 1993$126.70M+130.8%
  • 1992$54.90M+138.7%
  • 1991$23.00M+23.7%
  • 1990$18.60M-60.9%
  • 1989$47.60M—

Operating Cash Flow values are taken from Thermo Fisher Scientific's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Operating Cash Flow at Thermo Fisher Scientific (TMO)

Operating Cash Flow for Thermo Fisher Scientific (TMO): headline value $1.19B · YoY -9.8%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of Thermo Fisher Scientific (TMO) operating cash flow is $7.82B – declined 9.8% year-over-year.

Looking at the 2020–2025 (5 years) stretch, Thermo Fisher Scientific operating cash flow compounded at -1.2% per year, with a net decline across the window.

Thermo Fisher Scientific operating cash flow peaked at $9.54B in 2021; the latest annual figure is $7.82B in 2025 (18.1% below peak).

The highest annual operating cash flow of $9.54B was reported in 2021. The lowest in the available history was $18.60M in 1990.

Thermo Fisher Scientific Operating Cash Flow by Year

Thermo Fisher Scientific Operating Cash Flow 2025: $7.82B

Thermo Fisher Scientific posted operating cash flow of $7.82B in 2025, declined 9.8% below 2024.

Thermo Fisher Scientific Operating Cash Flow 2024: $8.67B

In 2024, Thermo Fisher Scientific reported operating cash flow of $8.67B, edged up 3.1% from 2023.

Thermo Fisher Scientific Operating Cash Flow 2023: $8.41B

Thermo Fisher Scientific operating cash flow in 2023 was $8.41B, declined 8.2% below 2022.

Thermo Fisher Scientific Operating Cash Flow 2022: $9.15B

2022's operating cash flow for Thermo Fisher Scientific came in at $9.15B, edged down 4.1% below 2021.

Thermo Fisher Scientific Operating Cash Flow 2021: $9.54B

Thermo Fisher Scientific operating cash flow in 2021 was $9.54B.

See more financial history for Thermo Fisher Scientific (TMO).

Sector peers by Operating Cash Flow

Healthcare peers of Thermo Fisher Scientific (TMO), ranked by their latest operating cash flow

Frequently asked questions

Thermo Fisher Scientific (TMO) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview